CVS Health Corp | CVS | Long at $61.00

٣٠ سبتمبر

CVS Health Corp will need a revision to its business model in order to survive an ever-changing retail/pharmacy environment. However, with a P/E of 10x, debt-to-equity of less than 1x, growing cash flow, and dividend yield of 4.3%, the stock seems quite undervalued. Perhaps activist investors will soon step in, but if history repeats, there may be a nice bounce ahead as the price consolidates in the 50S and low 60s. Thus, near its current price of $61, CVS is in a personal buy zone.

Target #1 = $66.00
Target #2 = $68.00
Target #3 = $75.00
Target #4 = $79.00

١ نوفمبر

ملاحظة

Target #1 reached for an 8.2% gain.

١٧ ديسمبر

أغلقت الصفقة: تم الوصول لوقف الخسارة

Yeah, that one didn't play nicely... Stopped reached after hitting new low for an overall loss.